Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
Polycyclic aromatic hydrocarbons (PAH) and many other important chemical
carcinogens are metabolically activated to electrophilic epoxides that
alkylate DNA. Mutational activation of proto-oncogenes by these
reactions constitutes one of the initial steps in chemical
carcinogenesis. The view that epoxides are direct alkylating agents has
dominated our concepts of tumor imitation for our two decades. However,
we have discovered that halides catalyze both the formation of
benzo[a]pyrene diol epoxide (BPDE)-DNA adducts and tetrols. Preliminary
in vitro studies demonstrate that cholorhydrins derived from the epoxides
are intermediates. What we propose to do in this application is to
determine (i) whether halide catalysis generally occurs with PAH and non-
PAH epoxides, (ii) whether other halides (iodide and bromide) catalyze
adduct formation, (iii) if halide catalysis occurs in vivo, and (iv)
whether steric properties of carcinogenic epoxides contribute to the
extent that they undergo halide catalysis. In the absence of halide ions,
the acid-catalyzed formation of BPDE-DNA adducts and tetrols yields
almost exclusively trans products (with reference to the 9,10-positions
of the hydrocarbon moiety). Halide catalysis results in a substantial
increase in cis product formation which is diagnostic for the involvement
of these anions. We will test whether halide catalysis is generally
involved in carcinogenic epoxide reactions by studying a series of
hydrocarbons (BADE, DMBADE, MCDE, and styrene oxide) and determining the
extent to which halides catalyze their reactions. We will determine
whether iodide and bromide are, in addition to chloride, capable of
catalyzing adduct formation. Product ratios for hydrolysis will be
determined in media and inside cells as well as for adduct formation in
CHO cells. Chlorohydrins of the carcinogenic epoxides. These data will
allow us to determine whether chlorohydrins are formed in cell culture
media and whether they are involved in adduct formation in vivo.
Finally, we will determine the role of steric crowding in the stability
and properties of chlorohydrins by studying a series of PAH epoxides with
varying degrees of hindrance in the bay region. Halide catalysis in the
reactions of carcinogenic epoxides has several important implications.
Previous studies on DNA binding in vitro will need to be re-interpreted
depending on the amount of chloride used. This will be particularly
important where substantial amounts of cis adducts were obtained.
Furthermore, our view of carcinogenesis initiation mechanisms will have
to be altered if significant amounts of halide catalysis occur in vivo.
One of the long term goals of this study and other work in my laboratory
is to develop a complete understanding of initiation mechanisms since
this will be essential if we are to discover rational approaches to
preventing carcinogenic damage and the tumors that result from it.
National Institute of Environmental Health Sciences
CFDA Code
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
01-August-1994
Project End Date
31-July-1999
Budget Start Date
01-August-1994
Budget End Date
31-July-1995
Project Funding Information for 1994
Total Funding
$128,335
Direct Costs
$88,787
Indirect Costs
$39,548
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Environmental Health Sciences
$128,335
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01ES006869-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01ES006869-01
Patents
No Patents information available for 1R01ES006869-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01ES006869-01
Clinical Studies
No Clinical Studies information available for 1R01ES006869-01
News and More
Related News Releases
No news release information available for 1R01ES006869-01
History
No Historical information available for 1R01ES006869-01
Similar Projects
No Similar Projects information available for 1R01ES006869-01